Brind.

Michael Yee provided stock views on Novo Nordisk and Eli Lilly on October 8, 2026.

1 report, 1 independent Updated Oct 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novo Nordisk Eli Lilly and Company

Keep exploring

The entities involved

Novo Nordisk
Danish pharmaceutical company
- Major pharmaceutical companies, including Viking Therapeutics, Eli Lilly, and Novo Nordisk, are advancing their weight loss drug pipelines.Sun 23:36
- Personnel changes at Novo Nordisk and Lundbeck, including Mike Doustdar succeeding Lars Fruergaard Jørgensen and proposals for Lundbeck's board.Sun 18:20
Eli Lilly and Company
American pharmaceutical company
- Eli Lilly and Company acquired Point and established a supply agreement with EUZ.06:37
- Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.Sun 23:25

Related events

YHB Investment Advisors Inc. grew its holdings in Eli Lilly and Company stock.Oct 8
Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.Jun 18
Clue and Novo Nordisk have partnered to provide health services.Oct 8
Bristol-Myers Squibb and Novo Nordisk are noted as competitors in the healthcare sector.Oct 11

Coverage

Newest first; wire copies grouped

Oct 8fool.com